ReviewMolecular psychiatry2026
Dysfunctional circular RNA network in major depressive disorder: dissecting the cell identity and potential clinical applications.
Review in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation.Precision clinical medicine · 2026Review
- Schaftoside inhibits neuroinflammation and exerts antidepressant effects through METTL3-mediated m6A modification of circ_0001470 sponging miR-183-5p to regulate MAP3K1 expression.Psychopharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Circular RNAs (circRNAs), characterized by their unique covalently closed circular structure, are highly stable, conserved, and expressed in a tissue-, cell-, and developmental stage-specific manner. A lot of evidence has indicated that circRNAs play a crucial role in diversified biological and pathological processes by sponging microRNAs (miRNAs), interacting with proteins, or being translated into particular proteins, etc. Recent advancements in bioinformatics have revealed a close association between circRNAs and the development of neuropsychiatric diseases, including major depressive disorder (MDD). Increasingly, researchers emphasize the significant impact of abnormal circRNA expression and its targets on the pathogenesis of MDD. However, the detailed mechanisms involved remain elusive. Research has articulated the important role of neuronal cell dysfunction in MDD. Glia cells are the most abundant cell type in the central nervous system (CNS) and provide critical roles in MDD via intercellular-interaction-dependent pathogenic mechanisms. In this review, we extensively explore the newly identified roles of circRNAs in MDD. We summarize their novel mechanisms from cellular and molecular perspectives by deciphering how circRNAs interplay between neurons and neurogliocytes, followed by how circRNAs are tailored to synaptic plasticity and stress pathways under a variety of circumstances. Last, we discuss and predict their potential clinical values of diagnosis and therapy.
Indexed as
Identifiers
40847006What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.